Mm. Ohayon, PREVALENCE OF DSM-IV DIAGNOSTIC-CRITERIA OF INSOMNIA - DISTINGUISHINGINSOMNIA RELATED TO MENTAL-DISORDERS FROM SLEEP DISORDERS, Journal of Psychiatric Research, 31(3), 1997, pp. 333-346
Epidemiological studies of insomnia in the general population have rep
orted high prevalence rates. However, few have applied diagnostic crit
eria from existing classification systems. Consequently, it is not pos
sible to determine whether subjects suffered from a sleep disorder or
whether the insomnia constituted a symptom of a mental disorder. Insom
nia and its relationship with other mental disorders was investigated
in the general population using DSM-IV criteria. A representative samp
le of 5622 subjects from the French population were interviewed about
their sleep habits over the telephone by lay interviewers. The course
and content of interviews were customized by means of the Sleep-Eval k
nowledge-based system. A total of 18.6% of the sample reported insomni
a complaints. The presence of insomnia complaints, lasting for at leas
t one month with daytime repercussions was found for 12.7% of the samp
le. Subsequently, subjects were classified according to the Sleep Diso
rder decision-making process proposed by the DSM-IV classification, bu
t without the recourse of polysomnographic recordings. Specific sleep
disorder diagnoses were given for 5.6% of the sample, mostly as insomn
ia related to another mental disorder; primary insomnia was given for
1.3% of the sample. Primary mental disorder diagnoses were supplied fo
r 8.4% of the sample, mostly as generalized anxiety disorder. The resu
lts of this investigation emphasize the need to use classifications to
determine whether subjects with insomnia complaints suffer from a sle
ep disorder or whether insomnia constitutes a symptom of some other me
ntal disorder. These distinctions are of utmost importance as they hav
e a bearing on the choice of treatment. Conversely, diagnoses were obt
ained by lay interviews, which may have caused a lack of recognition a
nd/or discrimination for light or borderline symptomatology. (C) 1997
Elsevier Science Ltd.